CRBU
Caribou Biosciences Inc

2,509
Mkt Cap
$231.88M
Volume
836,252.00
52W High
$3.00
52W Low
$0.66
PE Ratio
-1.39
CRBU Fundamentals
Price
$2.45
Prev Close
$2.49
Open
$2.51
50D MA
$2.13
Beta
1.73
Avg. Volume
950,909.43
EPS (Annual)
-$1.65
P/B
1.40
Rev/Employee
$67,986.40
Loading...
Loading...
Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
147

Frequently Asked Questions

What is Market Cap of Caribou Biosciences Inc?
What is the 52-week high for Caribou Biosciences Inc?
What is the 52-week low for Caribou Biosciences Inc?
What is Caribou Biosciences Inc stock price today?
What was Caribou Biosciences Inc stock price yesterday?
What is the PE ratio of Caribou Biosciences Inc?
What is the Price-to-Book ratio of Caribou Biosciences Inc?
What is the 50-day moving average of Caribou Biosciences Inc?
How many employess does Caribou Biosciences Inc has?

Latest CRBU News

View

Advertisement|Remove ads.

Advertisement|Remove ads.